Aphria
VC Fund
Leamington, Canada
Aphria is a VC fund in Leamington focused on Cannabis and Apps. Aphria is integrating their growing expertise with Health Canada’s new Marijuana for Medical Purposes Regulations (MMPR) for medicinal marijuana industry. Possessing greenhouse related growing experience in plant and produce related expertise since 1943, Aphria is positioned to be an industry leader in providing patients with the highest qualitymedical marijuana. Aphria has developed integrated greenhouse growing solutions specifically focused on quality production of cannabis. With the authorization of quantity scale marijuana growing, Aphria greenhouse operations are a natural fit.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Aphria invests in
Stages Aphria invests in
Countries Aphria invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Post-IPO Equity
- $450k–$23M
Investment Focus
Industry
- Cannabis 4 (100%)
- Apps 1 (25%)
- Mobile 1 (25%)
- Internet 1 (25%)
- Lifestyle 1 (25%)
Stage
- Post-IPO Equity 2 (50%)
- Series A 1 (25%)
- Series B 1 (25%)
Country
- Canada 3 (75%)
- United States 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Cole Cacciavillani
Founder
|
Founder | Total investments: 0 | Find email | |
David Schacter
Software Development
|
Software Development | Total investments: 0 | Find email | |
Sarah Dobbin
Director of Medical Division
|
Director of Medical Division | Total investments: 0 | Find email | |
Vic Neufeld
CEO
|
CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| SOL is an international cannabis company that offers strategic investments and partnerships. It follows a private equity strategy focusing on thematic investments in growth industries that disrupt traditional markets. Sol Global was founded in 2014 and is headquartered in Calgary, Alberta, Canada. | $22.8M / Post-IPO Equity / Feb 13, 2018 | ||
| Tokyo Smoke is a modern lifestyle collective and a cultural movement. Our aim is to create an immersive physical experience, across verticals that touch our hearts, with the care, craft and expertise. Fundamentally, we believe Coffee, Clothing, and Cannabis are the lifeblood of the Creative Class. The Brand Tokyo Smoke is the touchstone for beauty,design, and quality in a society hungry for inclusive but sophisticated, designer brands. The combination of creativity, passion, and originality, has formed a sophisticated urban brand that goes beyond products. By integrating into the creative drivers of consumers, those being coffee, clothing and cannabis, Tokyo Smoke can help shape how today’s individual lives their life. This puts us in a unique position to interact with consumers within multiple touch points throughout their day.Specifically, this is what the verticals allow us to do:• Coffee: the shops function as a brand experience center to host our customers and the community• Clothing: provides a foundation to interact with our customers and ambassadors across the world and to establish the legitimacy and reach of the brand• Cannabis: brings beauty, form and function to an underserved consumer, with Tokyo Smoke as the first brand to provide an aspirational and inspirational lifestyle that transcends the Cannabis cultureCurrently, there are two coffee bars / luxury Cannabis accessory shops that function as experience centers. The line of luxury men’s clothing is available at GotStyle, in the coffee shop as well as other select retailers. The line of Tokyo Smoke Cannabis is soon to be on shelf in Washington State with a first of its kind deal about to be signed in Canada. | $4.7M / Series B / Oct 24, 2017 | ||
| MassRoots is a social network technology platform for the cannabis consumers and community with over 900,000 users, 170 million user-to-user interactions, and 500 actively posting dispensaries. People use the MassRoots app on IOS and Android to find smoking buddies, share their cannabis experiences with like-minded friends, and stay connected withlocal dispensaries. MassRoots was founded under the belief that a future where humans can freely experience the positive effects of cannabis is fundamentally better than one in which they cannot. Today, MassRoots is actively fostering the community and developing the technologies to make this future a reality, with the ultimate goal of worldwide cannabis legalization. | $450K / Post-IPO Equity / Mar 30, 2017 | ||
| We are committed to establishing a standard of care missing from the medical cannabis industry until now. Backed by nearly three years of research and development, Resolve is set to become the leading medical solution for accurate, metered cannabis care. | $5M / Series A / Mar 28, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Aphria invest in?
Aphria invests primarily in Cannabis, Apps and Mobile startups, most often at Post-IPO Equity and Series A stage. Most of the 4 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Aphria's check size?
Aphria typically joins rounds of $450k–$23M at Post-IPO Equity. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Aphria participates in.
How do I contact Aphria?
Public channels for Aphria include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Aphria?
The team at Aphria includes Cole Cacciavillani (Founder), David Schacter (Software Development) and Sarah Dobbin (Director of Medical Division). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
